RxDoctor Payments DataLook up a doctor →

Kelly McCaul, MD

Hematology & Oncology · Sioux Falls, SDNPI 1295701522

Payments from drug & device makers

$1,507,277in general payments, 2019–2025

Across 1,153 payments — averaging $1307.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bristol Myers Squibb$299K
  • Incyte Corporation$283K
  • Karyopharm Therapeutics Inc.$243K
  • Johnson & Johnson$146K
  • E.r. Squibb & Sons, L.L.C.$135K
  • Takeda Pharmaceuticals U.S.A., Inc.$119K
  • plus $282K from 32 others
$935in research payments, 2019–2025

Across 1 payment — averaging $935.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bristol Myers Squibb$935

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,507,277 in reported general payments places this provider in the 85th percentile of 28 hematology & oncology providers in South Dakota.

See all hematology & oncology providers in South Dakota

Medicare billing

Part B allowed, 2024
$46,109
Medicare patients
46
Services billed
392

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Sioux Falls

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →